Photosensitivity associated with anaplastic lymphoma kinase inhibitors: A review of postmarketing cases reported to FDA and published in the literature.

Photodermatol Photoimmunol Photomed

Division of Pharmacovigilance, Office of Surveillance and Epidemiology, Center for Drug Evaluation and Research, U.S. Food and Drug Administration, Silver Spring, Maryland, USA.

Published: May 2023

Download full-text PDF

Source
http://dx.doi.org/10.1111/phpp.12829DOI Listing

Publication Analysis

Top Keywords

photosensitivity associated
4
associated anaplastic
4
anaplastic lymphoma
4
lymphoma kinase
4
kinase inhibitors
4
inhibitors review
4
review postmarketing
4
postmarketing cases
4
cases reported
4
reported fda
4

Similar Publications

Want AI Summaries of new PubMed Abstracts delivered to your In-box?

Enter search terms and have AI summaries delivered each week - change queries or unsubscribe any time!